Ardevora Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$11.1M Sell
64,746
-73,562
-53% -$11.3M 0.99% 41
2023
Q3
$20.5M Sell
138,308
-31,170
-18% -$5.64M 1% 28
2023
Q2
$37M Sell
169,478
-75,352
-31% -$16.8M 0.9% 41
2023
Q1
$53.6M Buy
244,830
+32,107
+15% +$6.97M 0.96% 38
2022
Q4
$44.3M Sell
212,723
-129,786
-38% -$28.5M 0.75% 59
2022
Q3
$74.8M Buy
342,509
+64,984
+23% +$14.8M 1.35% 3
2022
Q2
$58.2M Buy
277,525
+32,400
+13% +$6.9M 0.95% 8
2022
Q1
$59.4M Sell
245,125
-49,667
-17% -$12M 0.77% 80
2021
Q4
$76.8M Buy
+294,792
New +$76.5M 0.82% 52
2021
Q2
Sell
-223,893
Closed -$43.4M 132
2021
Q1
$43.4M Buy
223,893
+3,200
+1% +$642K 0.65% 111
2020
Q4
$46.9M Sell
220,693
-29,800
-12% -$5.94M 0.72% 103
2020
Q3
$42.9M Buy
250,493
+1,300
+0.5% +$240K 0.79% 92
2020
Q2
$47.8M Buy
249,193
+248,493
+35,499% +$40.7M 0.94% 31
2020
Q1
$103K Hold
700
﹤0.01% 103
2019
Q4
$108K Buy
700
+100
+17% +$14.4K ﹤0.01% 93
2019
Q3
$81K Sell
600
-352,100
-100% -$46.1M ﹤0.01% 99
2019
Q2
$43M Sell
352,700
-18,300
-5% -$2.03M 1.05% 20
2019
Q1
$38.6M Buy
371,000
+41,100
+12% +$4.24M 1.01% 18
2018
Q4
$37.6M Buy
+329,900
New +$35.3M 1.13% 5

Other funds holding RMD

Ardevora Asset Management's RMD Position: Q4 2023 in Review

Ardevora Asset Management reduced its ResMed (RMD) stake by 53% in Q4 2023, selling an estimated $11.3M and leaving 64,746 shares worth $11.1M. The position accounts for 0.99% of the portfolio, ranked #41.

Ardevora Asset Management first reported a position in RMD in Q4 2018 and has held it in 19 quarters since. The position peaked at $76.8M in Q4 2021. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Ardevora Asset Management held 64,746 shares of ResMed worth $11.1M as of Q4 2023.
  • Ardevora Asset Management sold 73,562 ResMed shares in Q4 2023, an estimated $11.3M.
  • ResMed made up 0.99% of Ardevora Asset Management's portfolio in Q4 2023, its #41 holding.
  • Ardevora Asset Management first reported a position in ResMed in Q4 2018 and has held it in 19 quarters since.
  • Ardevora Asset Management's ResMed position peaked at $76.8M in Q4 2021.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Ardevora Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.